Related Experiment Videos
DNA sequence associated with chromosome translocations in mouse plasmacytomas
Summary
A novel DNA sequence, non-immunoglobulin-associated rearranging DNA (NIARD), is involved in chromosome translocations in mouse plasmacytomas. This finding suggests NIARD plays a role in malignant transformation and cancer development.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Research
Background:
- Aberrant DNA rearrangements in immunoglobulin genes are hallmarks of B-cell malignancies like plasmacytomas.
- A specific DNA sequence, termed non-immunoglobulin-associated rearranging DNA (NIARD), has been observed to rearrange in murine plasmacytomas.
Purpose of the Study:
- To determine the chromosomal location of NIARD.
- To investigate the mechanism behind NIARD rearrangements in plasmacytomas.
- To explore the potential role of NIARD in malignant transformation.
Main Methods:
- Analysis of mouse-Chinese hamster somatic cell hybrids using DNA digestion and Southern transfer.
- Hybridization with a NIARD-specific probe.
- Restriction endonuclease digestion and Southern blotting.
Main Results:
- NIARD was mapped to mouse chromosome 15 in the germ line.
- NIARD rearrangements were frequently detected in plasmacytomas but not in normal lymphocytes.
- Evidence suggests a translocation event, rcpT(12;15), involving chromosomes 12 and 15 in plasmacytomas.
Conclusions:
- NIARD is located on chromosome 15 and participates in translocations with chromosome 12 in plasmacytomas.
- NIARD rearrangements are associated with specific chromosomal abnormalities in cancer.
- These findings have implications for understanding the molecular basis of malignant transformation.